PNP Therapeutics Inc. is a clinical-stage biopharmaceutical company based in Birmingham, Alabama, specializing in the development of innovative cancer therapeutics. With a focus on their proprietary platform technology, Gedeptin, PNP Therapeutics aims to revolutionize cancer treatment through targeted approaches. Through their cutting-edge research and development efforts, PNP Therapeutics has made significant progress in the field of cancer-fighting technology, as evidenced by their successful Phase I clinical trial. Their commitment to advancing cancer therapeutics has led to important partnerships, such as the recent exclusive license agreement with GeoVax, Inc., further solidifying their position as a leader in the industry.Generated from the website